Literature DB >> 26071576

Rapid conversion of autoimmune hypophysitis to an empty sella with immediate lowering of the serum IgG4 level. Case Report.

Yasuto Nakasone1, Kazuhiro Oguchi2, Yuka Sato1, Yosuke Okubo3, Keishi Yamauchi1, Toru Aizawa1.   

Abstract

An 87-year-old man was admitted with fatigue, anorexia, vomiting, urinary incontinence, and a depressive state. His consciousness was evaluated as a 13 on the Glasgow Coma Scale (E4V3M6), and he had a body temperature of 36.4°C, a blood pressure of 91/60 mmHg, and a heart rate of 88 beats/min. General laboratory data were unremarkable except for a mildly elevated serum creatinine level. The plasma levels of growth hormone, luteinizing hormone, and follicle stimulating hormone were depressed. On the other hand, the prolactin level was elevated, and the corticotropin, cortisol, and thyrotropin levels were within the reference ranges. Cranial magnetic resonance imaging (MRI) revealed the marked swelling of the pituitary gland and the infundibular stalk, and the serum immunoglobulin G4 (IgG4) level was elevated (2.85 g/L; reference range, 0.048-1.05 g/L). Accordingly, a diagnosis of IgG4-related autoimmune hypophysitis (AH) was made. The patient responded well to glucocorticoid therapy, but the presence of diabetes insipidus was revealed and was subsequently controlled using desamino-D-arginine vasopressin (DDAVP). To our surprise, an empty sella was apparent on an MRI examination performed on Day 12. The patient's serum IgG4 level had decreased in a log-linear manner with a half-life of 30 days, which was comparable to the half-life of IgG4 in control subjects (21 days). At a 16-month follow-up examination, no substantial changes in the morphology or function of the pituitary gland were noted. In conclusion, an empty sella developed within 12 days after the clinical onset of AH in the present case, suggesting that an empty sella may be the direct outcome of AH. The conversion of AH to an empty sella was associated with an immediate shutdown of IgG4 overproduction.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26071576

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  6 in total

1.  Infrequent organ involvement of IgG4-related diseases: a literature review.

Authors:  Jie Chang; Wen Zhang
Journal:  Clin Rheumatol       Date:  2018-03-03       Impact factor: 2.980

Review 2.  Critical review of IgG4-related hypophysitis.

Authors:  Junpei Shikuma; Kenshi Kan; Rokuro Ito; Kazuo Hara; Hiroyuki Sakai; Takashi Miwa; Akira Kanazawa; Masato Odawara
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

Review 3.  IgG4-related hypophysitis.

Authors:  Alireza Amirbaigloo; Fatemeh Esfahanian; Marjan Mouodi; Nasser Rakhshani; Mehdi Zeinalizadeh
Journal:  Endocrine       Date:  2021-04-10       Impact factor: 3.633

4.  Clinical course of IgG4-related hypophysitis presenting with focal seizure and relapsing lymphocytic hypophysitis.

Authors:  Kanchana Ngaosuwan; Therdkiat Trongwongsa; Shanop Shuangshoti
Journal:  BMC Endocr Disord       Date:  2015-10-29       Impact factor: 2.763

Review 5.  Overlap of Post-obstructive Diuresis and Unmasked Diabetes Insipidus in a Case of IgG4-related Retroperitoneal Fibrosis and Tuberoinfundibular Hypophysitis: A Case Report and Review of the Literature.

Authors:  Midori Sasaki Yatabe; Kimio Watanabe; Yoshimitsu Hayashi; Junichi Yatabe; Satoshi Morimoto; Atsuhiro Ichihara; Masaaki Nakayama; Tsuyoshi Watanabe
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

Review 6.  Clinical Characteristics of 76 Patients with IgG4-Related Hypophysitis: A Systematic Literature Review.

Authors:  Yujuan Li; Hua Gao; Zhen Li; Xinxin Zhang; Yizhi Ding; Fengao Li
Journal:  Int J Endocrinol       Date:  2019-12-18       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.